The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of neoadjuvant pertuzumab-containing regimens on pathologic complete response rates in stage II-III HER2-neu positive breast cancer: A retrospective, single institutional experience.
 
Rashmi Krishna Murthy
Consulting or Advisory Role - Daiichi Sankyo; Genentech
Research Funding - Merrimack (Inst); Oncothyreon (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Oncothyreon
 
Takeo Fujii
No Relationships to Disclose
 
Kenneth R. Hess
Travel, Accommodations, Expenses - Angiochem
 
Akshara Singareeka Raghavendra
No Relationships to Disclose
 
Bora Lim
No Relationships to Disclose
 
Carlos Hernando Barcenas
No Relationships to Disclose
 
Hong Amy Zhang
No Relationships to Disclose
 
Mariana Chavez-Mac Gregor
Consulting or Advisory Role - InVitae; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Elizabeth Ann Mittendorf
Consulting or Advisory Role - Amgen; OBI Pharma
Research Funding - Antigen Express (Inst); Galena Biopharma (Inst); Genentech/Roche (Inst)
 
Jennifer Keating Litton
Consulting or Advisory Role - Medivation; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Genentech; medivation; Novartis; pfizer
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Medivation
 
Sharon Hermes Giordano
No Relationships to Disclose
 
Alastair Mark Thompson
Travel, Accommodations, Expenses - Novartis (I)
 
Vicente Valero
No Relationships to Disclose
 
Debu Tripathy
Consulting or Advisory Role - Nektar; Novartis; Pfizer; Puma Biotechnology
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Naoto T. Ueno
No Relationships to Disclose